What's the difference between Attruby and Vyndamax?
Both Attruby (acoramidis) and Vyndamax (tafamidis) are oral medications used to treat ATTR-CM (transthyretin amyloid cardiomyopathy), but they have some key differences:
How they work
- Both are TTR stabilizers that prevent the transthyretin protein from breaking apart Show Full Answer
What's the difference between Attruby and Vyndamax?
Both Attruby (acoramidis) and Vyndamax (tafamidis) are oral medications used to treat ATTR-CM (transthyretin amyloid cardiomyopathy), but they have some key differences:
How they work:
- Both are TTR stabilizers that prevent the transthyretin protein from breaking apart and forming harmful amyloid deposits in the heart
- They work through similar mechanisms but are different medications
Dosing:
- Attruby is typically taken twice daily as a tablet
- Vyndamax dosing may differ (specific frequency not detailed in available information)
Approval and availability:
- Attruby was FDA-approved in 2024, making it a newer treatment option
- Vyndamax has been available longer
- Insurance coverage varies: some Medicare Part D plans don't currently cover Vyndamax in certain states, though most states cover another form called Vyndaqel
Effectiveness:
- Recent studies showed Attruby reduced the risk of cardiovascular death or repeat hospital stays by 49% compared to placebo
- Both medications have shown benefits in treating ATTR-CM
Your doctor can help determine which medication is most appropriate for your specific situation, considering factors like insurance coverage, dosing preferences, and your individual health needs.
January 21
Join
Your Privacy Choices
